{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T23:36:20Z","timestamp":1778715380586,"version":"3.51.4"},"reference-count":61,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1016\/j.neuropharm.2005.12.010","type":"journal-article","created":{"date-parts":[[2006,2,10]],"date-time":"2006-02-10T12:29:39Z","timestamp":1139574579000},"page":"884-896","source":"Crossref","is-referenced-by-count":37,"title":["Partial lesion of the serotonergic system by a single dose of MDMA results in behavioural disinhibition and enhances acute MDMA-induced social behaviour on the social interaction test"],"prefix":"10.1016","volume":"50","author":[{"given":"Romeo D.","family":"Ando","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita","family":"Benko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Ferrington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eszter","family":"Kirilly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul A.T.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gyorgy","family":"Bagdy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2005.12.010_bib1","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1017\/S1461145701002632","article-title":"Anxiety-like effects induced by acute fluoxetine, sertraline or m-CPP treatment are reversed by pretreatment with the 5-HT2C receptor antagonist SB-242084 but not the 5-HT1A receptor antagonist WAY-100635","volume":"4","author":"Bagdy","year":"2001","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2005.12.010_bib2","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s00213-004-1787-9","article-title":"Effects of a single dose of 3,4-methylenedioxymethamphetamine on circadian patterns, motor activity and sleep in drug-naive rats and rats previously exposed to MDMA","volume":"173","author":"Balogh","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2005.12.010_bib3","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/s00213-003-1753-y","article-title":"Effect of 5-HT depletion by MDMA on hyperthermia and Arc mRNA induction in rat brain","volume":"173","author":"Beveridge","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2005.12.010_bib4","first-page":"217","article-title":"Anxiogenic activity of methylenedioxymethamphetamine (Ecstasy): an experimental study","volume":"14","author":"Bhattacharya","year":"1998","journal-title":"Biog. Amines"},{"key":"10.1016\/j.neuropharm.2005.12.010_bib5","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/BF02244124","article-title":"Effect of serotonergic lesion on \u201canxious\u201d behaviour measured in the elevated plus-maze test in the rat","volume":"101","author":"Briley","year":"1990","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2005.12.010_bib6","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1097\/00006231-200108000-00007","article-title":"Long-term effects of \u2018ecstasy\u2019 abuse on the human brain studied by FDG PET","volume":"22","author":"Buchert","year":"2001","journal-title":"Nucl. Med. Commun."},{"key":"10.1016\/j.neuropharm.2005.12.010_bib7","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0028-3908(02)00407-0","article-title":"Reduced social interaction following 3,4-methylenedioxymethamphetamine is not associated with enhanced 5-HT 2C receptor responsivity","volume":"44","author":"Bull","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2005.12.010_bib8","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.neuropharm.2003.08.004","article-title":"Decreased social behaviour following 3,4-methylenedioxymethamphetamine (MDMA) is accompanied by changes in 5-HT2A receptor responsivity","volume":"46","author":"Bull","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2005.12.010_bib9","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.drugalcdep.2004.04.003","article-title":"Impulsivity, risk taking and recreational \u2018ecstasy\u2019 (MDMA) use","volume":"76","author":"Butler","year":"2004","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2005.12.010_bib10","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1615\/CritRevNeurobiol.v10.i3-4.70","article-title":"A functional neuroanatomy of anxiety and fear: implications for the pathophysiology and treatment of anxiety disorders","volume":"10","author":"Charney","year":"1996","journal-title":"Crit. Rev. Neurobiol."},{"key":"10.1016\/j.neuropharm.2005.12.010_bib11","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1111\/j.1476-5381.1995.tb15037.x","article-title":"The hyperthermic and neurotoxic effects of \u2018Ecstasy\u2019 (MDMA) and 3,4 methylenedioxyamphetamine (MDA) in the Dark Agouti (DA) rat, a model of the CYP2D6 poor metabolizer phenotype","volume":"115","author":"Colado","year":"1995","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2005.12.010_bib12","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/(SICI)1099-1077(199705\/06)12:3<221::AID-HUP854>3.0.CO;2-C","article-title":"Ecstasy (MDMA) in recreational users: self-reported psychological and physiological effects","volume":"12","author":"Davison","year":"1997","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2005.12.010_bib13","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/syn.890010513","article-title":"Autoradiographic localization of [3H]-paroxetine-labeled serotonin uptake sites in rat brain","volume":"1","author":"De Souza","year":"1987","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2005.12.010_bib14","unstructured":"Ferrington, L., McBean, D.E., Olverman, H.J., Leith, J.L., Kelly, P.A.T. Previous exposure to 3,4-methylenedioxymethamphetamine (MDMA) alters cerebral metabolic response to 8-OH-DPAT in Dark Agouti rats. pA2 online, in press."},{"key":"10.1016\/j.neuropharm.2005.12.010_bib15","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00213-001-0931-z","article-title":"Long-term changes in social interaction and reward following repeated MDMA administration to adolescent rats without accompanying serotonergic neurotoxicity","volume":"159","author":"Fone","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2005.12.010_bib16","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00213-004-1820-z","article-title":"MDMA: fact and fallacy, and the need to increase knowledge in both the scientific and popular press","volume":"173","author":"Green","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2005.12.010_bib17","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/BF02246288","article-title":"Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or \u201cEcstasy\u201d)","volume":"119","author":"Green","year":"1995","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2005.12.010_bib18","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s00213-002-1158-3","article-title":"On the anxiogenic and anxiolytic nature of long-term cerebral 5-HT depletion following MDMA","volume":"162","author":"Green","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2005.12.010_bib19","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1124\/pr.55.3.3","article-title":"The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, \u201cecstasy\u201d)","volume":"55","author":"Green","year":"2003","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2005.12.010_bib20","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0163-7258(95)98597-J","article-title":"5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: more than 30 years of research","volume":"65","author":"Griebel","year":"1995","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2005.12.010_bib21","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.neuint.2004.02.004","article-title":"Increased behavioural activity of rats in forced swimming test after partial denervation of serotonergic system by parachloroamphetamine treatment","volume":"45","author":"Haidkind","year":"2004","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2005.12.010_bib22","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/(SICI)1098-2396(199907)33:1<16::AID-SYN2>3.0.CO;2-8","article-title":"Effects of 5,7-dihydroxytryptamine depletion of tissue serotonin levels on extracellular serotonin in the striatum assessed with in vivo microdialysis: relationship to behavior","volume":"33","author":"Hall","year":"1999","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2005.12.010_bib23","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s00213-002-1265-1","article-title":"Long-term partial 5-HT depletion: interference of anxiety and impulsivity?","volume":"164","author":"Harro","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2005.12.010_bib24","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0006-8993(01)02256-9","article-title":"Chronic variable stress and partial 5-HT denervation by parachloroamphetamine treatment in the rat: effects on behavior and monoamine neurochemistry","volume":"899","author":"Harro","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2005.12.010_bib25","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0166-4328(03)00220-1","article-title":"Acute and long-term consequences of single MDMA administration in relation to individual anxiety levels in the rat","volume":"149","author":"Ho","year":"2004","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2005.12.010_bib26","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/0028-3908(84)90099-6","article-title":"5-HT and anxiety","volume":"23","author":"Iversen","year":"1984","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2005.12.010_bib27","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0893-133X(97)00195-4","article-title":"MDMA elicits behavioral and neurochemical sensitization in rats","volume":"18","author":"Kalivas","year":"1998","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2005.12.010_bib28","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0031-9384(00)00374-7","article-title":"High social anxiety and low aggression in Fawn-Hooded rats","volume":"71","author":"Kantor","year":"2000","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2005.12.010_bib29","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1111\/j.1476-5381.1995.tb17240.x","article-title":"Cerebrovascular consequences of repeated exposure to NG-nitro-l-arginine methyl ester","volume":"116","author":"Kelly","year":"1995","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2005.12.010_bib30","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1017\/S146114570500581X","article-title":"Acute and long-term effects of a single dose of MDMA on aggression in Dark Agouti rats","volume":"9","author":"Kirilly","year":"2006","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2005.12.010_bib60","unstructured":"Kirilly, E., T\u00f3th, Z.E., Gerber, G., Palkovits, M., Bagdy, G., 2005. 3,4-Methylenedioxymethamphetamine (MDMA) modulates serotonin transporter mRNA expression in the rat brainstem. Society for Neuroscience 35th Annual Meeting, November 12\u201316 2005, Washington DC, P111.12."},{"key":"10.1016\/j.neuropharm.2005.12.010_bib31","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0278-5846(99)00112-8","article-title":"Effects of 3,4-methylenedioxy-methamphetamine (MDMA) on anxiety in mice tested in the light-dark box","volume":"24","author":"Maldonado","year":"2000","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2005.12.010_bib32","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1006\/phrs.2001.0824","article-title":"MDMA (\u201cecstasy\u201d) exhibits an anxiogenic-like activity in social encounters between male mice","volume":"44","author":"Maldonado","year":"2001","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.neuropharm.2005.12.010_bib33","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1038\/sj.npp.1300185","article-title":"Increased anxiety 3 months after brief exposure to MDMA (\u201cEcstasy\u201d) in rats: association with altered 5-HT transporter and receptor density","volume":"28","author":"McGregor","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2005.12.010_bib34","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00213-003-1452-8","article-title":"Increased anxiety and \u201cdepressive\u201d symptoms months after MDMA (\u201cecstasy\u201d) in rats: drug-induced hyperthermia does not predict long-term outcomes","volume":"168","author":"McGregor","year":"2003","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2005.12.010_bib35","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s002130100902","article-title":"A comparison between Dark Agouti and Sprague\u2013Dawley rats in their behaviour on the elevated plus-maze, open-field apparatus and activity meters, and their response to diazepam","volume":"159","author":"Mechan","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2005.12.010_bib36","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s002130100900","article-title":"A study of the effect of a single neurotoxic dose of 3,4-methylenedioxymethamphetamine (MDMA; \u201cecstasy\u201d) on the subsequent long-term behaviour of rats in the plus maze and open field","volume":"159","author":"Mechan","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2005.12.010_bib37","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/BF02316866","article-title":"Dissociation of multiple effects of acute LSD on exploratory behavior in rats by ritanserin and propranolol","volume":"105","author":"Mittman","year":"1991","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2005.12.010_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2005.04.009","article-title":"Serotonin (1A) receptor involvement in acute 3,4-methylenedioxymethamphetamine (MDMA) facilitation of social interaction in the rat","author":"Morley","year":"2005","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2005.12.010_bib39","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0014-2999(01)01512-6","article-title":"Increased anxiety and impaired memory in rats 3 months after administration of 3,4-methylenedioxymethamphetamine (\u201cecstasy\u201d)","volume":"433","author":"Morley","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2005.12.010_bib40","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0014-2999(00)00749-4","article-title":"(+\/\u2212)-3,4-methylenedioxymethamphetamine (MDMA, \u2018Ecstasy\u2019) increases social interaction in rats","volume":"408","author":"Morley","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2005.12.010_bib41","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0278-5846(98)00100-6","article-title":"Behavioral profile of 3,4-methylenedioxy-methamphetamine (MDMA) in agonistic encounters between male mice","volume":"23","author":"Navarro","year":"1999","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2005.12.010_bib42","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0028-3908(98)00029-X","article-title":"The relationship between the degree of neurodegeneration of rat brain 5-HT nerve terminals and the dose and frequency of administration of MDMA (\u2018ecstasy\u2019)","volume":"37","author":"O'Shea","year":"1998","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2005.12.010_bib43","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0006-3223(92)90145-P","article-title":"MDMA (Ecstasy) precipitation of panic disorder","volume":"32","author":"Pallanti","year":"1992","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2005.12.010_bib44","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000026666","article-title":"Human research on MDMA (3,4-methylene- dioxymethamphetamine) neurotoxicity: cognitive and behavioural indices of change","volume":"42","author":"Parrott","year":"2000","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.neuropharm.2005.12.010_bib45","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/hup.351","article-title":"Human psychopharmacology of ecstasy (MDMA): a review of 15 years of empirical research","volume":"16","author":"Parrott","year":"2001","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2005.12.010_bib46","first-page":"105","article-title":"Psychobiological problems in heavy \u2018ecstasy\u2019 (MDMA) polydrug users","volume":"60","author":"Parrott","year":"2000","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2005.12.010_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2004.10.001","article-title":"Memory deficit and reduced anxiety in young adult rats given repeated intermittent MDMA treatment during the periadolescent period","author":"Piper","year":"2004","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2005.12.010_bib48","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00213-004-1784-z","article-title":"Acute methylenedioxymethamphetamine administration: effects on local cerebral blood flow and glucose utilisation in the Dark Agouti rat","volume":"173","author":"Quate","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2005.12.010_bib49","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/BF02316872","article-title":"Alterations in hippocampal function following repeated exposure to the amphetamine derivative methylenedioxymethamphetamine (\u201cEcstasy\u201d)","volume":"105","author":"Sharkey","year":"1991","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2005.12.010_bib50","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0006-3223(02)01574-3","article-title":"Induction of c-Fos expression in specific areas of the fear circuitry in rat forebrain by anxiogenic drugs","volume":"53","author":"Singewald","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2005.12.010_bib51","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1111\/j.1471-4159.1977.tb10649.x","article-title":"The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat","volume":"28","author":"Sokoloff","year":"1977","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2005.12.010_bib52","first-page":"427","article-title":"An integrated hypothesis for the serotonergic axonal loss induced by 3,4-methylenedioxymethamphetamine","volume":"19","author":"Sprague","year":"1998","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuropharm.2005.12.010_bib53","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.pbb.2004.02.007","article-title":"The effects of MDMA pretreatment on the behavioural effects of other drugs of abuse in the rat elevated plus-maze test","volume":"77","author":"Sumnall","year":"2004","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2005.12.010_bib54","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/sj.npp.1300347","article-title":"Chronic fluoxetine treatment partly attenuates the long-term anxiety and depressive symptoms induced by MDMA (\u2018Ecstasy\u2019) in rats","volume":"29","author":"Thompson","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2005.12.010_bib61","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/00001756-199902250-00020","article-title":"Effects of acute and chronic fluoxetine treatment of CRH-induced anxiety","volume":"10","author":"To","year":"1999","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2005.12.010_bib55","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.tips.2004.08.001","article-title":"Neurotoxicity of MDMA (ecstasy): the limitations of scaling from animals to humans","volume":"25","author":"de la Torre","year":"2004","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2005.12.010_bib56","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00228-005-0965-y","article-title":"MDMA (ecstasy) pharmacokinetics in a CYP2D6 poor metaboliser and in nine CYP2D6 extensive metabolisers","volume":"61","author":"de la Torre","year":"2005","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2005.12.010_bib57","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/sj.npp.1395197","article-title":"Psychological and cardiovascular effects and short-term sequelae of MDMA (\u201cecstasy\u201d) in MDMA-naive healthy volunteers","volume":"19","author":"Vollenweider","year":"1998","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2005.12.010_bib58","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1080\/02791072.2002.10399951","article-title":"Acute psychological and neurophysiological effects of MDMA in humans","volume":"34","author":"Vollenweider","year":"2002","journal-title":"J. Psychoactive Drugs"},{"key":"10.1016\/j.neuropharm.2005.12.010_bib59","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1176\/ajp.146.1.119b","article-title":"\u201cEcstasy\u201d (MDMA)-induced panic","volume":"146","author":"Whitaker-Azmitia","year":"1989","journal-title":"Am. J. Psychiatry"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390805004363?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390805004363?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T11:08:06Z","timestamp":1656068886000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390805004363"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":61,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["S0028390805004363"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2005.12.010","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2006,6]]}}}